(The Consortium of Investigators of Modifiers of BRCA1/2)


Any group that can contribute DNA and basic phenotype and epidemiological risk factor data from at least 92 female BRCA1 and BRCA2 mutation carriers with a pathogenic mutation can participate in CIMBA. Carriers must be aged 18 or over and both affected and unaffected individuals are eligible.

  • Phenotypic and Epidemiological data fields
  • Genotyping QC guidelines - November 2008

  • | CIMBA Home | About CIMBA | Eligibility | Projects | Publications | Study Groups | Contact | Meetings | Links | Members login | Return to Members